Vulnerabilities

Vulnerability · CVE-2025-0131

An incorrect privilege management vulnerability in the OPSWAT MetaDefender Endpoint Security SDK used by the Palo Alto Networks GlobalProtect™ app on Windows devices allows a local

Published May 14, 2025 · catalog updated Feb 26, 2026 · OPSWAT MetaDefender Endpoint Security SDK

Check this week

CVE-2025-0131 is not in CISA KEV. FIRST estimates a 16.00% chance of exploitation in the next 30 days. Check whether you run OPSWAT MetaDefender Endpoint Security SDK.

Gaps on this record

  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
High7.1
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
16.00%
Remediation
Version ranges on file
Affected products
vendor OPSWAT MetaDefender Endpoint Security SDK 4.3.0 <4.3.4451

An incorrect privilege management vulnerability in the OPSWAT MetaDefender Endpoint Security SDK used by the Palo Alto Networks GlobalProtect™ app on Windows devices allows a locally authenticated non-administrative Windows user to escalate their privileges to NT AUTHORITY\SYSTEM. However, execution requires that the local user also successfully exploits a race condition, which makes this vulnerability difficult to exploit.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • vendor OPSWAT MetaDefender Endpoint Security SDK 4.3.0 <4.3.44514.3.0 <4.3.4451

How to fix CVE-2025-0131

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

CVE-2025-0131 is not in CISA KEV. FIRST estimates a 16.00% chance of exploitation in the next 30 days. Check whether you run OPSWAT MetaDefender Endpoint Security SDK.

Which versions are affected?

Compare what you have installed with OPSWAT MetaDefender Endpoint Security SDK 4.3.0 <4.3.4451 4.3.0 <4.3.4451. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

No weakness class is stored. EPSS 16.00%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Technology hubs

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. May 14, 2025 · EUVD

    Detected

    An incorrect privilege management vulnerability in the OPSWAT MetaDefender Endpoint Security SDK used by the Palo Alto Networks GlobalProtect™ app on Windows devices allows a locally authenticated non-administrative Windows user to escalate their privileges to NT AUTHORITY\SYSTEM. However, execution requires that the local user also successfully exploits a race condition, which makes this vulnerab

  2. Feb 26, 2026 · EUVD

    Updated

    An incorrect privilege management vulnerability in the OPSWAT MetaDefender Endpoint Security SDK used by the Palo Alto Networks GlobalProtect™ app on Windows devices allows a locally authenticated non-administrative Windows user to escalate their privileges to NT AUTHORITY\SYSTEM. However, execution requires that the local user also successfully exploits a race condition, which makes this vulnerab

Sources

  • CVE.orgVulnerability recordCVE-2025-0131

    Official CVE identifier

    cve.org
  • EUVDVulnerability recordEUVD-2025-14911

    An incorrect privilege management vulnerability in the OPSWAT MetaDefender Endpoint Security SDK used by the Palo Alto Networks GlobalProtect™ app on Windows devices allows a locally authenticated non-administrative Windows user to escalate their privileges to NT AUTHORITY\SYSTEM

    euvd.enisa.europa.eu

References

Freshness

Last verified in this catalog Oct 17, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.